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CAMP-dependent protein kinase appears to play a 
role in CAMP-induced gene expression in mammalian 
cells. There exist two major types of CAMP-dependent 
protein kinaae, type I and type II, which are distin- 
guished by their regulatory subunits, RI and RII, re- 
spectively. We investigated the role of type I and type 
II protein kinase in the CAMP-induced gene expression 
by either stable or co-transfection of RI,, RII,, or RIIB 
gene in an expression vector together with so- 
matostatin-chloramphenicol acetyltransferase (SS- 
CAT) fusion gene using a CAMP-unresponsive mutant 
pheochromocytoma cell line (A126-lB2). Introduction 
of the RIIB gene restored the capability of these cells to 
induce the SS-CAT gene expression in response to 
forskolin stimulus and induced a changed morphology 
which resembled that of wild type. The RII, gene also 
induced SS-CAT gene expression but to a lesser degree 
than that achieved by the RII, gene, whereas the RI, 
gene had no effect. The induction of SS-CAT gene 
expression by the RIIB gene was specifically blocked 
by the 21-mer RIIB antisense oligodeoxynucleotide. 
These results show for the first time that type II but 
not type I regulatory subunit of CAMP-dependent pro- 
tein kinase is essential for a CAMP-induced gene tran- 
scription. 
In recent years, there has been remarkable progress in the 
identification and characterization of the promoter-regulatory 
regions (CRE)’ of CAMP-regulated genes (1). However, little 
is understood about the mechanism responsible for the induc- 
tion of these genes by CAMP. CAMP in mammalian cells acts 
through CAMP-dependent protein kinase. There are two types 
of CAMP-dependent protein kinase, type I and type II, which 
share a common catalytic (C) subunit but contain distinct 
regulatory subunits, RI and RII, respectively (2, 3). Four 
different regulatory subunits (RI, (4), RI, (5), RII, (6), and 
RIIp (7)) have been identified at the gene/mRNA level. Two 
distinct C subunits (C,, (8) and C,, (9, 10)) have also been 
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identified, however, preferential co-expression of either one 
of these C subunits with either type of protein kinase R 
subunit has not been found (10). 
It was an intriguing observation (11) that the CRE-contain- 
ing somatostatin gene is not inducible by CAMP in a mutant 
pheochromocytoma (PC12) line, A126-lB2 (12), which lacks 
type II CAMP-dependent protein kinase but contains the wild 
type level of type I protein kinase activity. Thus, the A126- 
lB2 cell line offers an experimental model in which the 
differential role of CAMP-dependent protein kinase isozymes 
in CRE transcription can be studied. 
In the present study, by the use of gene transfection and 
antisense strategy, we examined the role of the regulatory 
subunits of protein kinase isozymes in the induction of the 
CRE-containing somatostatin gene in A126-lB2 cells. We 
also examined the effect of the introduction of the regulatory 
subunit gene of protein kinase on the cell morphology and 
biological response of cells to CAMP analogs. 
EXPERIMENTAL PROCEDURES 
Cell Lines-A-126-lB2 (12) (kindly provided by J. A. Wagner, 
Harvard Medical School and Dana Farber Cancer Institute, Boston, 
MA) and PC12 (American Type Culture Collection, Rockville, MD) 
cells were grown in Dulbecco’s modified Eagle’s medium containing 
10% fetal calf serum, 5% horse serum, penicillin (100 units/ml), and 
streptomycin (100 rg/ml), and were fed every 3-4 days and passaged 
every 7 days (11). 
Expression Vector Plasmids-The plasmid human RII,, ( hRIIp) 
(kindly provided by T. Jahnsen, Institute of Pathology, Rikshospit- 
alet, Oslo, Norway) is a 3.6-kb EcoRI fragment containing the full- 
length hRIId cDNA (13). A retroviral vector, OT1521 (14) (kindly 
provided by M. L. McGeady, National Cancer Institute, Bethesda, 
MD), which is derived from fpGV-1 (15, 16), the MSV-derived retro- 
viral vector, contains the mouse metallothionein 1 (MT-l) promoter 
as an internal promoter and the neomycin resistance gene (G418) 
(Fig. 1). The vector MT-R& was constructed by inserting the 3.6-kb 
hRIIB EcoRI fragment into OT1521 at an EcoRI site at the 3’ end of 
the MT-1 sequence, placing the hRII,, gene under the transcriptional 
control of the MT-1 nromoter (Fig. 1). The vector MT-RII.. was 
constructed in the same manner as the MT-RII, vector by insertion 
of the 1.65.kb EcoRI fragment of human RII,, (hRII,,) cDNA (17) 
(kindly provided by T. Jahnsen) into the OT1521 vector. The plasmid 
HL-REV RI,, (18) (kindly provided by G. S. McKnight, University 
of Washington, Seattle, WA) contains the coding region of mouse 
RI,, which is under control of the long terminal repeat of the Ha- 
MSV. 
Transfections and Transient Assays-Cells ( lo6 cells/lOO-mm dish) 
were transfected with DNA consisting of 20 pg of somatostatin- 
chloramphenicol acetyltransferase fusion gene (A-71 CAT plasmid 
(ll), kindly provided by M. R. Montminy, the Salk Institute, San 
Diego, CA) and 10 pg of calf thymus DNA carrier, with or without 10 
c(g of the expression vector plasmid (see above) of the regulatory 
subunit of protein kinase, by the calcium phosphate precipitation 
method (19). After 24 h, fresh medium was added, and the indicated 
cells were treated for 24 h with forskolin (10 NM) and/or CdClz (2 
FM) and then assayed for CAT activity. Cells were harvested and cell 
lysates were prepared as described by Gorman et al. (19). Lysates (75 
wg of protein) were incubated with 1.0 FCi of [YZJchloramphenicol 
and 0.2 mM acetyl-CoA in 150 mM Tris-HCl, pH 7.6, for 60 min at 
37 “C. Under these conditions, CAT activity was linear with time. 
Reaction products were analyzed by thin-layer chromatography (19). 
Production of Stable Lines-A126-lB2 cells (lo6 cells/lOO-mm 
dish) were transfected with 10 gg of MT-RI&, plasmid by the calcium 
phosphate precipitation method (19). 48 h after the transfection, the 
neomycin analog G418 was added to the medium, and the resistant 
colonies were isolated after 2-3 weeks of selection. Colonies were 
grown in the presence of CdCln (2 pM) and were analyzed for produc- 
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tion 01 RII,, by photoaffinity labeling of cell extracts with 8-N.$-[‘“PI 
CAMP followed by immunoprecipitation with anti-RI1 antiserum 
(kindly provided by S. 0. Dtiskeland, University of Bergen, Bergen, 
Norway) as previously described (20, 21). 
Olifiodfox~lnucleotides-We synthesized (Milligen Biosearch 8700 
DNA synthesizer (Bedford, MA)) the 21-mer antisense oligodeoxy- 
nucleotides complementary to the human RI,, (22), human RII,. (17), 
or human RII,, (13) mRNA transcripts starting from the first codon. 
The oligomers had the following sequences: RI,, antisense, 5’-GGG- 
GGT-ACT-GCC-AGA-CTC-CAT-3’; RII,, antisense, 5’-CGC-CGG- 
GAT-CTC-GAT-GCT-CAT-3’; RII,, antisense, 5’-CGG-GAT-CTG- 
GAT-GTG-GCT-CAT-3’. 
RESULTS 
Construction of RII Expression Vectors-The absence of 
somatostatin gene transcription in a mutant PC12 cell line, 
A126-lB2, has been correlated with a deficiency in type II 
CAMP-dependent protein kinase activity (11, 12). In an at- 
tempt to restore the somatostatin gene transcription in A126- 
lB2 cells by manipulation of type II protein kinase activity, 
we constructed retroviral vectors for type II protein kinase 
regulatory subunits, RII,, and RII,,. The plasmids MT-RII,, 
and MT-RI&, were constructed by insertion of human RII,, 
(17) or RII,, (13) cDNA into the OT1521 retroviral vector (14) 
to obtain inducible expression of RII,, or RII,,. The plasmids 
contain the coding region of either RII,, or RII,, preceded by 
the metal ion (Cd or Zn)-inducible metallothionein promoter 
(Fig. 1). The plasmids also contain a gene coding for neomycin 
phosphotransferase, which confers G418 resistance and allows 
selection of stable transfectants (Fig. 1). OT1521 vector with- 
out RI1 gene was used as the control vector. 
Stable Transfectants of RII,, Gene Restore Somatostatin Gene 
Transcription-We transfected A126-lB2 cells with either 
MT-RII,, or control plasmid, OT1521, which confers G418 
resistance. Following selection with G418, we identified colo- 
nies that overexpressed RII,, by treatment of cells with CdCl, 
(2 PM) and analyzing RII,, protein levels in cell extracts with 
the photoaffinity labeling (8-N,,-[‘“P]cAMP)-immunoprecip- 
itation (anti-RI1 antiserum) method (20, 21). These transfec- 
tants (A126-RII,,) contained 3-5-fold increased levels of a 52- 
kDa protein that is antigenically related to the rat brain RII,, 
as compared with parent A126-lB2 cells (AV relative level f 
S.D.: 4.5 f 0.5 for A126-RIL; 1.0 + 0.1 for A126-lB2). In 
colonies carrying the OT1521 control vector, RII,, levels re- 
mained unchanged as compared with the parent A126-lB2 
cells. 
We examined whether these cells containing the RII,, gene 
are capable of somatostatin gene transcription. The parent 
A126-lB2 cells exhibited low basal levels of somatostatin- 
chloramphenicol acetyltransferase (SS-CAT) fusion gene 
transcription activity in the presence of forskolin (Fig. 2) (11). 
This basal activity varied from 0 to 0.8% as shown by the 
percent conversion of substrate (Fig. 2B). When A126-lB2 
cells were stably transfected with the RII,, gene (A126-RII,,) 
there was a 56-fold induction of SS-CAT gene upon treatment 
of cells wit.h CdCl, and forskolin over the basal activity (Fig. 
2B). The A126-RII,, colonies that overexpressed 3-5-fold RII,, 
SD. t+l 
I I - 
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MT-1 hRU,, 
FIG. 1. Schematic diagram of MT-RII# retroviral vector 
plasmid. OT1521 (14) containing the MT-1 promoter as an internal 
promoter, was derived from tbGV-1 (15, 16), the MSV retroviral 
vector. The hRII., EcoRI fragment (13) was introduced into OT1521 
at an EcoRI site at the 3’ end of the MT-1 sequence. LTR, long 
terminal repeat; S.D., splice donor site; $, packaging site; pRR ORI, 
origin of replication from pBR322; G418, gentamicin-resistant gene; 
MT-I, mouse metallothionein-1 promoter gene; hRII,,, a 3.6-kb EcoRI 
fragment containing the full-length human RII,, cDNA. 
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FIG. 2. RI4 gene transfectants of A126-lB2 cells restore 
somatostatin gene transcription. A126-lB2 cells and A126-RII, 
cells (stable RII,, gene transfectants) (see “Experimental Procedures”) 
were transfected with the %-CAT (J-71 CAT) fusion gene, treated 
with CdCl, (2 pM) and forskolin (10 PM), and the CAT activity in cell 
extracts was analyzed by thin-layer chromatography to separate 
acetylated forms (upper spots) from unreacted chloramphenicol. -, 
+, lack of exposure or exposure to RII,, antisense (15 PM). Cells were 
treated with CdCl, (2 pM) and forskolin (10 pM) and exposed for the 
final 24 h of transection to the 21-mer RII,, antisense oligodeoxynu- 
cleotide. Similar results were obtained with 10, 20, and 40 pg of 1-71 
CAT plasmid. A, the results show CAT activity as measured by the 
percent conversion of chloramphenicol to acetylated forms; B, the 
data shown are the average +S.D. of four experiments identical to A. 
protein as compared with the parent A126-lB2 cells showed 
35-95-fold induction of CAT activity. The SS-CAT gene 
induction in A126-RII,, cells was CAMP-dependent, since 
treatment of cells with CdCl, only without forskolin did not 
induce the CAT activity (average percent substrate conver- 
sion = 0.4%). The SS-CAT activity was not induced in cells 
stably transfected with OT1521 control vector (average per- 
cent substrate conversion = 0.4%). 
Inhibition of Somatostatin Gene Transcription in RII,, Gene 
Stable Transfectants by RII,j Antisense Oligodeoxynucleotide- 
To provide direct evidence that the somatostatin gene tran- 
scription demonstrated above in A126-RIIJ cells is due to the 
presence of RI4 gene, we used antisense strategy. Cells ex- 
posed to the 21-mer RII,, antisense oligodeoxynucleotide (15 
PM) which specifically blocks RII,, production (21) exhibited 
a 90% reduction in SS-CAT transcription as compared with 
the control cells unexposed to the RII,, antisense oligomer 
(Fig. 2B). Neither RI,, antisense nor RII,, antisense oligode- 
oxynucleotide caused any reduction in the CAT activity (data 
not shown), indicating that the transfected RII,, gene was 
responsible for the somatostatin gene transcription in the 
stable transfectants, A126-RII,, cells. 
Restoration of Wild Type Cell Morphology and Biological 
Response to CAMP Analogs by RII,, Gene-As shown in Fig. 3, 
A126-lB2 cells, when stably transfected with the RII,, gene, 
displayed an altered morphology which resembled that of wild 
type PC12 cells. Moreover, these RII,, stable transfectants 
exhibited the same sensitivity as PC12 cells in their biological 
response to CAMP; cells exhibited growth inhibition upon 
treatment with CAMP analogs as did the wild type PC12 cells, 
whereas the mutant A126-lB2 cells were refractory to the 
analog treatment (data not shown). 
Overexpression of Type I Regulatory Subunit (RIJ Does Not 
Induce Somatostatin Gene Transcription-We examined 
whether overexpression of RI,, gene could also induce the 
somatostatin gene transcription in A126-lB2 cells using a co- 
transfection assay that has been used extensively to study the 
effects of steroid receptors and oncogenes on specific gene 
expression (23,24). We used the plasmid HL-REV-RI,, which 
contains the Harvey sarcoma virus long terminal repeat pro- 
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FIG. 3. RIIB gene induces wild type cell morphology in 
A126-lB2 mutant cells. PC12 A126-lB2, and A126-Rll., cells 
were seeded at 1 x 10’ cells/l.0 ml onto four-chamber tissue culture 
slides and grown for 48 h. A126-RII,, cells were grown in the presence 
of CdCl, (2 fiM). Cells were fixed and stained by Wright’s stain. x 75. 
0.4% 0.0% 0.5% 23% 0.6% 32% 
FIG. 4. Overexpression of RI, does not induce somatostatin 
gene transcription. 20 pg of SS-CAT fusion gene was co-transfected 
into A126-lB2 cells with 10 pg of HL-REV-RI,, or MT-RII,, plasmid. 
A126-lB2 and PC12 cells were also transfected with SS-CAT gene 
alone. +, treatment with both CdCl, (2 pM) and forskolin (10 pM) for 
the final 24 h of transection; -, Cd& (2 FM) treatment only. The 
results show CAT activity as measured by the percent conversion of 
chloramphenicol to acetylated forms. 
moter and allows strong constitutive overexpression of the 
mouse RI,, gene (18). The SS-CAT gene expression was not 
induced in cells co-transfected with the vector HL-REV-RI,, 
as in the control of A126-lB2 cells (Figs. 4 and 5). In contrast, 
cells co-transfected with the vector MT-RII,$ showed marked 
induction of the SS-CAT gene expression after stimulation 
with CdC12 and forskolin to the similar extent as that shown 
by wild type PC12 cells (Figs. 4 and 5). The failure of the RI,, 
gene to induce CAT activity was not due to low expression of 
RI,, protein; cells co-transfected with either a RI,, or RII,, gene 
demonstrated a 4-fold overexpression of RI,, or RII,, protein, 
respectively, as compared with the untransfected control cells 
(Fig. 5). Both A126-lB2 cells transfected with the RII,, gene 
and PC12 cells exhibited a low basal activity percent conver- 
sion = O-0.8%) of SS-CAT gene transcription in the absence 
of forskolin (Figs. 4 and 5), indicating that the somatostatin 
gene transcriptions in these cells were CAMP-dependent. Co- 
transfection with vector MT-RII,, also induced CAT activity 
in these cells but to a lesser degree than that by vector MT- 
RII,,. Thus, both type II regulatory subunits, RII,, and RII,$, 
PC12 Al26 A126- A126- 
B 
Rqj RI, 
”  PC12 Al26 Al26- A126- 
RllB RI, 
FIG. 5. Failure of somatostatin gene transcription in RI, 
gene transfectants is not due to the absence of functional RI, 
protein. A, the results are the average CAT activity (percent con- 
version) +S.D. of seven experiments identical to those of Fig. 4. B, 
integrated densitometry data from the photoaffinity labeling-immu- 
noprecipitation autoradiograms of RI,, and RII,,. The levels of RI,, 
and RII, are expressed relative to the levels of RII,, in PC12 cells 
(arbitrary unit = 1.0). The data shown are the average & SD. of 
seven experiments identical to those of Fig. 4 but without forskolin 
treatment. 
displayed positive effects on the somatostatin gene transcrip- 
tion, whereas the type I regulatory subunit, RI,,, had no effect. 
DISCUSSION 
We reported here that introduction of the type II regulatory 
subunit gene of CAMP-dependent protein kinase converted 
CAMP-unresponsive A126-lB2 cells to CAMP-responsive 
cells. This conversion was detected at the level of somatostatin 
gene (CRE) transcription as well as in the biological response 
of these cells and their morphology. Our finding that overex- 
pression of the RI subunit could not mimic the effect of the 
RI1 subunit in CRE transcription supports the specific role 
of RI1 in such transcription. Overexpression or suppression 
of one isoform of R subunits (RI or RII) results in a compen- 
satory change in the amount of the other isoform of R subunit; 
the amount of C subunit; however, remains the same (25-29). 
Thus, the CRE transcription induced in the mutant A126- 
lB2 cells by the introduction of the RI1 gene may not be due 
to a change in the level of C subunit but rather to a change 
in the ratio of type I to type II CAMP-dependent protein 
kinase holoenzymes. 
The role of the catalytic subunit of CAMP-dependent pro- 
tein kinase has been described in the basal rather than the 
CAMP-induced expression of the CRE-containing genes (30, 
31). Moreover, the role of the catalytic subunit of protein 
kinase has been shown in the transcription of both CRE 
(CAMP-responsive)- and AP-2 element (CAMP or phorbol 
ester-responsive)-containing genes (32, 33), indicating a lack 
of strict CRE specificity for the catalytic subunit effect. The 
induction of the somatostatin gene transcription by the RI1 
gene that we have demonstrated here was CAMP-dependent. 
A recent report by Wu and Wang (34), who demonstrated 
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